Today's Date: May 21, 2013 Search | Home | Contact | Services | Patent Attorney | Patent Search | Provisional Patent Application | Patent Application | Software Patent | Confidentiality Agreements

Northern Exposure – Canadian IP

Canada’s Copyright Modernization Act Comes Into Effect

Posted: Monday, Mar 11, 2013 @ 8:15 am | Written by Paul B. Bélanger & Andrés Canella | No Comments »
| Tags: , , , , , , ,
Posted in: Canada, Copyright, Guest Contributors, International, IP News, IPWatchdog.com Articles, Northern Exposure - Canadian IP, WIPO

Northern Exposure focuses on Canada and Canadian intellectual property laws, cases and procedures. From time to time we will also publish a Canadian perspective on important issues relating to US and Global intellectual property. For more articles please visit Northern Exposure – Canadian IP.

After receiving Royal Assent on June 29, 2012, the provisions of Bill C-11 came into force on November 7, 2012. Titled the Copyright Modernization Act, it has garnered the nickname “Canada’s SOPA” by some media outlets , referring to the highly contentious Stop Online Piracy Act bill introduced in the US House of Representatives that led to both physical and digital protests. Yet despite such bold claims, the Canadian amendment to the copyright act is a largely innocuous  piece of legislation that falls in line with its stated objectives.

Before delving into the major points of the bill and of its critics, it is important to note that an amendment has been a long time coming. The last one was in 1997. To put it into perspective: that was the year IBM’s Deep Blue defeated Garry Kasparov, and a good five years before any viable form of digital music became available for consumers. This means that for the better part of fifteen years, Canadians have been acting beyond the limitations of 20th century technological terminology. Instead, in the void of proper legislation, the Supreme Court of Canada has set the precedents, with five of the most recent rulings made in July 2012.



Northern Exposure: Pfizer Canada’s Viagra® Patent Invalidated

Posted: Sunday, Dec 16, 2012 @ 10:30 am | Written by France Côté | 1 Comment »
| Tags: , , , , , , , , ,
Posted in: Canada, Guest Contributors, International, IP News, IPWatchdog.com Articles, Northern Exposure - Canadian IP, Patent Fools™

Northern Exposure is a new series of articles that will focus on Canada and Canadian intellectual property laws, cases and procedures. From time to time we will also publish a Canadian perspective on important issues relating to US and Global intellectual property. For more articles please visit Northern Exposure – Canadian IP.

The Supreme Court of Canada rendered a decision on November 8, 2012 effectively canceling Viagra® Canadian patent a year and a half before its natural expiration date. This ends Pfizer’s exclusivity on the blockbuster erectile disfunction drug and opens the market up to generics. While certainly a press- worthy event, this decision does not change the Canadian patent landscape – but rather reinforces it.

The story begins when Teva Canada Limited, a generic company, filed for a “notice of compliance”, arguing that vague claims in the Pfizer patent would allow it to essentially produce a generic version of Viagra® through the backdoor. Normally, in a case where the “notice of compliance” is allowed, Teva Canada Limited would have been given the sole right to begin producing generics. The patent, however, would not be considered void. The Federal Court rejected the notice, so Teva appealed the decision to the Federal Court of Appeal and finally to the Supreme Court of Canada. The climb up the ladder essentially brought the case against the patent to a new level of scrutiny and interpretation.